Cabot Corp (CBT) stock

CBTNYSEMiscellaneous Chemical ProductsFiscal year ends September 30

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 4, 2026Score 19/3047% below fair value

$71.92−0.25 (-0.35%)

Close on Nov 13, 2026Market cap $3.71BP/E 13.3Yield 2.45%

Cabot statistics

113 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: –
Last ex-dividend date: Aug 28, 2026
Fundamentals through: Jun 30, 2026
Share price as of: Nov 13, 2026

Valuation ratiosIndustry

Market Cap: $3.71B; $272.32M
Enterprise Value: $4.87B; $146.23M
PE Ratio: 13.27; 25.11
PS Ratio: 0.81; 3.66
PB Ratio: 2.31; 2.00
P/TBV Ratio: 2.62; 2.22
P/FCF Ratio: 7.92; 17.86
P/OCF Ratio: 4.98; 12.99

Enterprise valuationIndustry

EV / Sales: 1.07; 2.57
EV / EBITDA: 5.54; 16.50
EV / EBIT: 7.37; 19.31
EV / FCF: 10.37; 22.27

Share statisticsIndustry

Shares Outstanding: 52M; 58M
Shares Change (YoY): -3.76%; 10.8%
Shares Change (QoQ): -1.12%; 0.50%
Float: 51M; 49M
Shares Held by Insiders: 2.06%; 11.7%
Shares Held by Institutions: 104.5%; 56.4%

Short sellingIndustry

Short Interest: 5M; –
Short Interest Change: 5.65%; -0.80%
Short % of Float: 10.3%; 9.01%
Short % of Shares Outstanding: 10.1%; 6.30%
Days to Cover: 13.79; 5.15

Stock price statisticsIndustry

52-Week High: $94.53; –
52-Week Low: $58.33; –
20-Day Moving Average: $73.26; –
50-Day Moving Average: $75.84; –
200-Day Moving Average: $79.58; –
Average True Range (14): $2.07; –
Price Change (1 Week): 1.22%; -1.15%
Price Change (1 Month): -4.72%; -4.87%
Price Change (3 Months): -16.8%; -21.0%
Price Change (6 Months): -11.2%; -20.6%
Price Change (YTD): 8.51%; -23.6%
Price Change (1 Year): 17.0%; -22.4%
Price Change (3 Years): -8.21%; -29.5%
Price Change (5 Years): 23.4%; -77.9%
Price Change (10 Years): 39.2%; -65.4%
Average Volume (10 Days): 425,133; –
Average Volume (20 Days): 404,113; –
Average Volume (90 Days): 406,172; –
Relative Volume: 0.67; 0.70
Relative Strength Index (14): 41.3; 43.4
Volatility (1 Year): 32.3%; 80.1%
Beta (5 Years): 0.93; 1.07

MarginsIndustry

Gross Margin: 23.5%; 53.1%
Operating Margin: 14.5%; -38.7%
Pretax Margin: 12.4%; -11.6%
Profit Margin: 6.39%; -31.6%
EBITDA Margin: 19.3%; -27.7%
FCF Margin: 10.3%; -9.56%

Returns on capitalIndustry

Return on Equity (ROE): 19.2%; -49.9%
Return on Assets (ROA): 7.50%; -40.6%
Return on Invested Capital (ROIC): 15.1%; -32.9%
Return on Capital Employed (ROCE): 23.2%; -37.9%

Financial positionIndustry

Current Ratio: 1.47; 3.30
Quick Ratio: 0.22; 2.39
Debt / Equity: 0.79; 0.49
Debt / EBITDA: 1.45; 3.15
Debt / FCF: 2.71; 4.65
Net Debt / EBITDA: 1.16; 1.97
Interest Coverage: 7.10; -6.35

GrowthIndustry

Revenue Growth (YoY): 16.6%; 6.82%
Net Income Growth (YoY): -32.8%; -14.4%
EPS Growth (YoY): -29.8%; -12.3%
FCF Growth (YoY): 48.9%; 6.85%
Revenue Growth (3Y CAGR): -4.93%; 2.25%
Revenue Growth (5Y CAGR): 7.27%; 6.41%
EPS Growth (3Y CAGR): 18.5%; 1.30%

EfficiencyIndustry

Asset Turnover: 1.17; 0.40
Inventory Turnover: 6.30; 2.73
Revenue Per Employee: $1.11M; $429.29K
Profits Per Employee: $70.98K; -$689.41K
Employee Count: 4,100; 74
WACC: 8.49%; 10.2%

Income statement (TTM)Industry

Revenue: $4.56B; $66.37M
Gross Profit: $1.07B; $120.78M
Operating Income: $660.00M; -$21.37M
Pretax Income: $566.00M; -$12.95M
Net Income: $291.00M; -$22.35M
EBITDA: $879.00M; -$17.21M
EPS (Diluted): $5.42; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $250.00M; $68.68M
Total Debt: $1.27B; $116.91M
Net Cash (Debt): -$1.02B; $17.76M
Net Cash Per Share: -$19.81; $0.80
Equity (Book Value): $1.61B; $53.89M
Book Value Per Share: $31.09; $1.50
Tangible Book Value: $1.42B; $27.13M
Working Capital: $530.00M; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: $746.00M; -$12.38M
Capital Expenditures: -$277.00M; -$1.00M
Free Cash Flow: $469.00M; -$18.21M
FCF Per Share: $9.08; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 7.84%; -21.8%
FCF Yield: 12.6%; -9.44%
Dividend Yield: 2.45%; 1.88%
Buyback Yield: 4.85%; -0.76%
Shareholder Yield: 7.29%; 0.00%
Dividend Per Share: $1.76; $0.83
Dividend Growth (YoY): 6.02%; 2.37%
Years of Dividend Growth: 4; 0
Payout Ratio: 41.6%; 55.4%
FCF Payout Ratio: 25.8%; 43.7%

Taxes and interestIndustry

Interest Expense: $93.00M; $2.90M
Income Tax: $233.00M; $73.00K
Effective Tax Rate: 41.2%; 20.9%

Scores and fair valueIndustry

Graham Number: $61.57; $19.34
Graham Upside: -14.4%; -46.6%
Altman Z-Score: 3.49; 0.23
Piotroski F-Score: 6; 4
Lynch Fair Value: $100.14; –
Lynch Upside: 39.2%; -28.9%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.

Period	CBT	S&P 500	Difference	CBT per year	S&P 500 per year
1 month	-4.7%	-3.0%	−1.7 pts
3 months	-16.2%	-2.8%	−13.4 pts
Year to date	+10.4%	+11.5%	−1.1 pts
1 year	+18.4%	+13.5%	+4.9 pts
3 years	+3.4%	+77.7%	−74.3 pts	+1.1%	+21.1%
5 years	+37.2%	+72.6%	−35.4 pts	+6.5%	+11.5%
10 years	+81.7%	+308.2%	−226.5 pts	+6.2%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

5M CBT shares were sold short on Oct 30, 2026, up 5.6% from the previous report, or 10.29% of the shares available to trade. At recent volumes it would take 13.8 days to buy them back. Over the last 20 sessions, 66.0% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	5,202,043	+5.6%	377,111	13.8
Oct 15, 2026	4,923,877	+11.4%	392,525	12.5
Sep 30, 2026	4,420,695	-5.1%	436,010	10.1
Sep 15, 2026	4,656,549	+2.1%	363,179	12.8
Aug 31, 2026	4,558,932	+10.9%	338,103	13.5
Aug 14, 2026	4,111,755	+9.4%	579,594	7.1
Jul 31, 2026	3,759,946	+8.2%	370,069	10.2
Jul 15, 2026	3,474,022	-7.8%	456,286	7.6
Jun 30, 2026	3,766,203	+16.9%	882,123	4.3
Jun 15, 2026	3,221,273	-10.7%	504,900	6.4
May 29, 2026	3,609,105	+16.6%	504,864	7.2
May 15, 2026	3,096,170	+9.1%	454,407	6.8